Opko Health (OPK) Net Cash Flow (2010 - 2026)

Opko Health has reported Net Cash Flow for 17 years, with the latest figure at -$26.3 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 1445.65% year-over-year to -$26.3 million; the trailing twelve-month figure through Mar 2026 stood at -$94.5 million (down 135.18% YoY), and the FY2025 full-year result was -$66.3 million, down 118.79% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$26.3 million, up from -$46.3 million in the prior quarter.
• The five-year high for Net Cash Flow was $321.8 million in Q3 2024, with the low at -$165.7 million in Q2 2025.
• Historically, Net Cash Flow has averaged $7.2 million across 5 years, with a median of -$27.4 million in 2022.
• The largest YoY upside for Net Cash Flow was 916.96% in 2024 against a maximum downside of 2199.92% in 2024.
• Opko Health's Net Cash Flow stood at -$29.3 million in 2022, then plunged by 48.1% to -$43.5 million in 2023, then surged by 840.37% to $321.8 million in 2024, then plunged by 114.39% to -$46.3 million in 2025, then soared by 43.28% to -$26.3 million in 2026.
• The last three Net Cash Flow figures came in at -$26.3 million (Q1 2026), -$46.3 million (Q4 2025), and $143.8 million (Q3 2025), per Business Quant data.